0001968582-24-000373.txt : 20240514 0001968582-24-000373.hdr.sgml : 20240514 20240514161624 ACCESSION NUMBER: 0001968582-24-000373 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IDEAYA Biosciences, Inc. CENTRAL INDEX KEY: 0001676725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474268251 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38915 FILM NUMBER: 24944594 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-6209 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Ideaya Biosciences, Inc. DATE OF NAME CHANGE: 20160609 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Hata Yujiro S CENTRAL INDEX KEY: 0001649119 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O XENCOR, INC. STREET 2: 111 WEST LEMON AVENUE CITY: MONROVIA STATE: CA ZIP: 91016 144 1 primary_doc.xml 144 0001649119 XXXXXXXX LIVE 0001676725 IDEAYA Biosciences, Inc. 001-38915 7000 Shoreline Court Suite 350 San Francisco CA 94080 6504436209 YUJIRO HATA CEO Common J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

175000 7238000 75686628 05/14/2024 Nasdaq Common 05/14/2024 Stock Option Exercise Issuer N 175000 05/14/2024 Cash Y The sales under this filing will include Cashless Option Exercises that will occur within 3 months from the date of this filing. 05/14/2024 12/22/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Yujiro Hata